Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Corrigendum] AHIF promotes glioblastoma progression and radioresistance via exosomes.

Created on 17 Jul 2026

Authors

Xuejun Dai, Keman Liao, Zhijun Zhuang, Binghong Chen, Zhiyi Zhou, Sunhai Zhou, Guoshi Lin, Feifei Zhang, Yingying Lin, Yifeng Miao, Zhiqiang Li, Renhua Huang, Yongming Qiu, Ruisheng Lin

Published in

International journal of oncology. Volume 69. Issue 3. Epub Jul 17, 2026.

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, in Fig. 2E on p. 264, the Transwell invasion assay results shown in the 'T98G‑AHIF KD' data panel appeared to potentially contain an overlapping section with the 'U251‑NC' data panel in Fig. 3E. After having re‑examined their original data, the authors have realized that Fig. 3 of the above paper was inadvertently assembled incorrectly. The revised version of Fig. 3, now showing replacement data for Fig. 3E (the Transwell results for the U251‑NC and U251‑AHIF‑OE experiments), is featured on the next page. Note that the error made in assembling Fig. 3 did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of International Journal of Oncology for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [International Journal of Oncology 54: 261‑270, 2019; DOI: 10.3892/ijo.2018.4621].

PMID:
42464675
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement